Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/4/16  and contains information from public web pages and contributions from the ZoomInfo community.

Lawrence H. Boise

Wrong Lawrence H. Boise?


Phone: (404) ***-****  
Email: l***@***.edu
Emory University
1520 Clifton Road NE Suite 234
Atlanta , Georgia 30322
United States

Company Description: Emory University, recognized internationally for its outstanding liberal arts colleges, graduate and professional schools, and one of the Southeast's leading health...   more

Employment History

15 Total References
Web References
Press Releases [cached]
Jun 18 - Lawrence Boise Joins Emory Winship Cancer Institute
UMSylvester - Comprehensive Cancer Center - Research, 6 July 2008 [cached]
Lawrence Boise, Ph.D.
UMSylvester - Comprehensive Cancer Center, 17 Jan 2008 [cached]
Lawrence H. Boise, Ph.D.
T.J. Martell Foundation - Leukemia, Cancer and AIDS Research, 18 Dec 2011 [cached]
This month's newsletter also features our second installment of Doctor's Corner, with Dr. Lawrence Boise of the Winship Cancer Center at Emory University.
Lawrence H. Boise, Ph.D. is Professor and distinguished scholar in the Department of Hematology and Medical Oncology at Emory School of Medicine's Winship Cancer Institute in Atlanta, Georgia. He joined the Martell team of research doctors in 2010 and we are excited to tell our supporters more about the work he is doing in the area of multiple myeloma.
News & Notes - UM/Sylvester - University of Miami School of Medicine, 3 April 2006 [cached]
Lawrence H. Boise, Ph.D., associate professor of Microbiology and Immunology at the University of Miami Leonard M. Miller School of Medicine, and his team found that some multiple myeloma cell lines responded to a compound called ZIO-101 in the lab.
Dr. Boise, Kelvin P. Lee, M.D., professor of Microbiology and Immunology, and their colleagues at the UM Miller School of Medicine have extensive experience working with arsenic trioxide (ATO), which was FDA-approved in September 2000 for the treatment of acute promyelocytic leukemia.
"We've had a longstanding interest in studying the mechanism, action and activity of arsenicals in multiple myeloma," said Boise.
"ZIOPHARM's studies have shown that ZIO-101 has much less toxicity and so if you can have similar anti-tumor activity with less toxicity you can give more of the drug, improving your results," said Boise.
Boise, Lee and their colleagues tested ZIO-101 on four different multiple myeloma cell lines, finding mixed results.
"So the ZIO-101 has a different mechanism or metabolism than arsenic trioxide," said Boise."What this means is patients who don't respond well to arsenic trioxide may respond well to ZIO-101, and vice versa."Claire Croutch, Ph.D., a postdoctoral fellow in the laboratory of Dr. Boise, will present the work in a research poster from 1 to 5 p.m. on Tuesday, April 4, at the AACR meeting in Washington, D.C.
Other People with the name "Boise":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.